Skip to Content

914 Results Found

  • Article
  • Open Access
5 Citations
7,362 Views
19 Pages

Balancing the Affinity and Tumor Cell Binding of a Two-in-One Antibody Simultaneously Targeting EGFR and PD-L1

  • Julia Harwardt,
  • Felix Klaus Geyer,
  • Katrin Schoenfeld,
  • David Baumstark and ,
  • Vera Molkenthin and
  • Harald Kolmar
  • + 1 author+ 0 author

The optimization of the affinity of monoclonal antibodies is crucial for the development of drug candidates, as it can impact the efficacy of the drug and, thus, the dose and dosing regimen, limit adverse effects, and reduce therapy costs. Here, we p...

(This article belongs to the Section Antibody Discovery and Engineering)
  • Article
  • Open Access
6 Citations
5,281 Views
12 Pages

24 January 2025

During the course of affinity maturation, antibodies exhibit enhanced antigen-binding affinities by altering the amino acids in their variable regions. Understanding the structural basis of these antibodies can be beneficial for antibody engineering....

  • Article
  • Open Access
4 Citations
5,509 Views
17 Pages

Binding Sites of Anti-Lcr V Monoclonal Antibodies Are More Critical than the Avidities and Affinities for Passive Protection against Yersinia pestis Infection in a Bubonic Plague Model

  • Kei Amemiya,
  • Jennifer L. Dankmeyer,
  • Sarah L. Keasey,
  • Sylvia R. Trevino and ,
  • Michael M. Wormald,
  • Stephanie A. Halasohoris,
  • Wilson J. Ribot,
  • David P. Fetterer,
  • Christopher K. Cote and
  • Robert G. Ulrich
  • + 7 authors+ 2 authors

3 August 2020

Plague is a zoonotic disease that is caused by Yersinia pestis. Monoclonal antibodies (mAbs) that bind to the V-antigen, a virulence factor that is produced by Y. pestis, can passively protect mice from plague. An analysis of protective mAbs that bin...

  • Article
  • Open Access
11 Citations
8,657 Views
19 Pages

3 August 2022

The accurate and efficient calculation of protein-protein binding affinities is an essential component in antibody and antigen design and optimization, and in computer modeling of antibody affinity maturation. Such calculations remain challenging des...

  • Article
  • Open Access
31 Citations
7,121 Views
14 Pages

SARS-CoV-2 Variants, RBD Mutations, Binding Affinity, and Antibody Escape

  • Lin Yang,
  • Jiacheng Li,
  • Shuai Guo,
  • Chengyu Hou and ,
  • Chenchen Liao,
  • Liping Shi,
  • Xiaoliang Ma,
  • Shenda Jiang,
  • Bing Zheng and
  • Xiaodong He
  • + 7 authors+ 2 authors

9 November 2021

Since 2020, the receptor-binding domain (RBD) of the spike protein of the novel severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) has been constantly mutating, producing most of the notable missense mutations in the context of “variants of...

(This article belongs to the Collection Feature Papers in 'Macromolecules')
  • Article
  • Open Access
6 Citations
3,955 Views
15 Pages

Tyrosine Sulfation at Antibody Light Chain CDR-1 Increases Binding Affinity and Neutralization Potency to Interleukine-4

  • Aaron M. D’Antona,
  • Julie M. Lee,
  • Melvin Zhang,
  • Clarence Friedman and ,
  • Tao He,
  • Lidia Mosyak,
  • Eric Bennett,
  • Laura Lin,
  • Maddison Silverman and
  • Xiaotian Zhong
  • + 12 authors+ 7 authors

5 February 2024

Structure and function of therapeutic antibodies can be modulated by a variety of post-translational modifications (PTM). Tyrosine (Tyr) sulfation is a type of negatively charged PTM that occurs during protein trafficking through the Golgi. In this s...

(This article belongs to the Section Biochemistry)
  • Article
  • Open Access
9 Citations
7,283 Views
20 Pages

Development and In-Depth Characterization of Bacteria Repellent and Bacteria Adhesive Antibody-Coated Surfaces Using Optical Waveguide Biosensing

  • Eniko Farkas,
  • Robert Tarr,
  • Tamás Gerecsei,
  • Andras Saftics and ,
  • Kinga Dóra Kovács,
  • Balazs Stercz,
  • Judit Domokos,
  • Beatrix Peter,
  • Sandor Kurunczi and
  • Robert Horvath
  • + 14 authors+ 9 authors

20 January 2022

Bacteria repellent surfaces and antibody-based coatings for bacterial assays have shown a growing demand in the field of biosensors, and have crucial importance in the design of biomedical devices. However, in-depth investigations and comparisons of...

(This article belongs to the Special Issue Feature Issue of Optical and Photonic Biosensors Section)
  • Article
  • Open Access
10 Citations
11,209 Views
17 Pages

27 September 2022

Yeast surface display techniques have been increasingly employed as a tool for both the discovery and affinity maturation of antibodies. In this study, we describe the use of yeast surface display for the selection and affinity maturation of antibodi...

(This article belongs to the Section Antibody Discovery and Engineering)
  • Article
  • Open Access
5 Citations
7,709 Views
19 Pages

Back-to-Germline (B2G) Procedure for Antibody Devolution

  • Anja Schrade,
  • Alexander Bujotzek,
  • Christian Spick,
  • Martina Wagner and ,
  • Johannes Goerl,
  • Xenia Wezler,
  • Guy Georges,
  • Roland E. Kontermann and
  • Ulrich Brinkmann
  • + 4 authors+ 0 author

26 August 2019

Bispecific antibodies (bsAbs) with avidity-enhanced specificity can be used to address target cells with increased specificity, ideally binding efficiently to cells that express two cognate antigens, yet not to cells that express only one of those. B...

  • Review
  • Open Access
189 Citations
31,215 Views
17 Pages

8 December 2016

The rapidly increasing application of antibodies has inspired the development of several novel methods to isolate and target antibodies using smart biomaterials that mimic the binding of Fc-receptors to antibodies. The Fc-binding domain of antibodies...

(This article belongs to the Special Issue Smart Biomaterials and Biointerfaces)
  • Article
  • Open Access
10 Citations
7,363 Views
24 Pages

Nonclinical Pharmacokinetics and Pharmacodynamics Characterization of Anti-CD79b/CD3 T Cell-Dependent Bispecific Antibody Using a Surrogate Molecule: A Potential Therapeutic Agent for B Cell Malignancies

  • Rajbharan Yadav,
  • Siddharth Sukumaran,
  • Tanja S. Zabka,
  • Jinze Li and ,
  • Amy Oldendorp,
  • Gary Morrow,
  • Arthur Reyes,
  • Melissa Cheu,
  • Jessica Li and
  • Meric A. Ovacik
  • + 14 authors+ 9 authors

The T cell-dependent bispecific (TDB) antibody, anti-CD79b/CD3, targets CD79b and CD3 cell-surface receptors expressed on B cells and T cells, respectively. Since the anti-CD79b arm of this TDB binds only to human CD79b, a surrogate TDB that binds to...

(This article belongs to the Section Pharmacokinetics and Pharmacodynamics)
  • Article
  • Open Access
14 Citations
2,759 Views
15 Pages

Revealing the SARS-CoV-2 Spike Protein and Specific Antibody Immune Complex Formation Mechanism for Precise Evaluation of Antibody Affinity

  • Ieva Plikusiene,
  • Vincentas Maciulis,
  • Vilius Vertelis,
  • Silvija Juciute and ,
  • Saulius Balevicius,
  • Arunas Ramanavicius,
  • Julian Talbot and
  • Almira Ramanaviciene
  • + 3 authors+ 0 author

25 August 2023

The profound understanding and detailed evaluation of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) spike (SCoV2-S) protein and specific antibody interaction mechanism is of high importance in the development of immunosensors for COVID...

(This article belongs to the Special Issue Immunoanalytical and Bioinformatics Methods in Immunology Research)
  • Article
  • Open Access
3 Citations
2,689 Views
22 Pages

Affinity Affects the Functional Potency of Anti-GD2 Antibodies by Target-Mediated Drug Disposition

  • Sascha Troschke-Meurer,
  • Maxi Zumpe,
  • Peter Moritz Ahrenberg,
  • Torsten Ebeling and ,
  • Nikolai Siebert,
  • Piotr Grabarczyk and
  • Holger N. Lode
  • + 2 authors+ 0 author

30 July 2025

Background/Objectives: High-risk neuroblastoma patients are treated with approved anti-ganglioside GD2 antibodies of moderate (dinutuximab beta; DB) and higher binding affinity (naxitamab; NAXI). We evaluated the functional potency of DB compared to...

(This article belongs to the Special Issue Precision Medicine and Targeted Therapies in Neuroblastoma)
  • Article
  • Open Access
2 Citations
1,952 Views
14 Pages

Fabrication of a Heptapeptide-Modified Poly(glycidyl Methac-Rylate) Nanosphere for Oriented Antibody Immobilization and Immunoassay

  • Xiaoxing Gong,
  • Jie Zhang,
  • Liyan Zhu,
  • Shu Bai and ,
  • Linling Yu and
  • Yan Sun
  • + 1 author+ 0 author

29 September 2024

Oriented antibody immobilization has been widely employed in immunoassays and immunodiagnoses due to its efficacy in identifying target antigens. Herein, a heptapeptide ligand, HWRGWVC (HC7), was coupled to poly(glycidyl methacrylate) (PGMA) nanosphe...

(This article belongs to the Special Issue Advances in the Formulation of Nanocarriers for Healthcare and Environmental Applications)
  • Review
  • Open Access
47 Citations
12,972 Views
16 Pages

3 March 2014

Linear polysaccharides are typically composed of repeating mono- or disaccharide units and are ubiquitous among living organisms. Polysaccharide diversity arises from chain-length variation, branching, and additional modifications. Structural diversi...

(This article belongs to the Special Issue Glycosylation and Glycoproteins)
  • Article
  • Open Access
7 Citations
4,748 Views
24 Pages

Focal Molography Allows for Affinity and Concentration Measurements of Proteins in Complex Matrices with High Accuracy

  • Lorin Dirscherl,
  • Laura S. Merz,
  • Ronya Kobras,
  • Peter Spies and ,
  • Andreas Frutiger,
  • Volker Gatterdam and
  • Dominik M. Meinel
  • + 2 authors+ 0 author

22 January 2025

Characterizing biomolecular receptor–ligand interactions is critical for research and development. However, performing analyses in complex, biologically relevant matrices, such as serum, remains challenging due to non-specific binding that ofte...

(This article belongs to the Special Issue Emerging Applications of Label-Free Optical Biosensors)
  • Article
  • Open Access
6 Citations
4,802 Views
19 Pages

27 November 2021

Inhibition of proprotein convertase subtilisin/kexin type 9 (PCSK9) has become an attractive therapeutic strategy for lowering low-density lipoprotein cholesterol (LDL-C). In this study, a novel high affinity humanized IgG1 mAb (named h5E12-L230G) ta...

(This article belongs to the Section Drug Discovery and Development)
  • Article
  • Open Access
24 Citations
7,760 Views
37 Pages

13 September 2024

The most recent wave of SARS-CoV-2 Omicron variants descending from BA.2 and BA.2.86 exhibited improved viral growth and fitness due to convergent evolution of functional hotspots. These hotspots operate in tandem to optimize both receptor binding fo...

(This article belongs to the Special Issue Emerging Variants of SARS-CoV-2)
  • Article
  • Open Access
22 Citations
8,326 Views
17 Pages

This work presents the use of peptide ligand HWRGWV and its cognate sequences to develop affinity adsorbents that compete with Protein A in terms of binding capacity and quality of the eluted product. First, the peptide ligand was conjugated to cross...

(This article belongs to the Special Issue Advances in Antibody Design and Antigenic Peptide Targeting)
  • Article
  • Open Access
24 Citations
7,152 Views
14 Pages

Binding Affinity of Trastuzumab and Pertuzumab Monoclonal Antibodies to Extracellular HER2 Domain

  • Victor L. Cruz,
  • Virginia Souza-Egipsy,
  • María Gion,
  • José Pérez-García and ,
  • Javier Cortes,
  • Javier Ramos and
  • Juan F. Vega
  • + 2 authors+ 0 author

The binding affinity of trastuzumab and pertuzumab to HER2 has been studied using both experimental and in silico methods. The experiments were conducted using the antibodies in their complete IgG form, as used in clinical therapy, and the extracellu...

(This article belongs to the Section Molecular Biology)
  • Article
  • Open Access
5 Citations
5,606 Views
21 Pages

22 December 2023

Developing a preventative vaccine for HIV-1 has been a global priority. The elicitation of broadly neutralizing antibodies (bNAbs) against a broad range of HIV-1 envelopes (Envs) from various strains appears to be a critical requirement for an effica...

(This article belongs to the Topic Molecular and Cellular Mechanisms of Diseases: HIV)
  • Article
  • Open Access
13 Citations
4,103 Views
20 Pages

Effect of Double Mutation (L452R and E484Q) on the Binding Affinity of Monoclonal Antibodies (mAbs) against the RBD—A Target for Vaccine Development

  • Deepali Gupta,
  • Mukesh Kumar,
  • Priyanka Sharma,
  • Trishala Mohan and ,
  • Amresh Prakash,
  • Renu Kumari and
  • Punit Kaur
  • + 2 authors+ 0 author

22 December 2022

The COVID-19 pandemic, caused by SARS-CoV-2, emerges as a global health problem, as the viral genome is evolving rapidly to form several variants. Advancement and progress in the development of effective vaccines and neutralizing monoclonal antibodie...

(This article belongs to the Section Vaccines Against Tropical and Other Infectious Diseases)
  • Review
  • Open Access
19 Citations
15,599 Views
17 Pages

Generating Recombinant Antibodies to Membrane Proteins through Phage Display

  • Renhua Huang,
  • Margaret M. Kiss,
  • Melissa Batonick,
  • Michael P. Weiner and
  • Brian K. Kay

One of the most important classes of proteins in terms of drug targets is cell surface membrane proteins, and yet it is a challenging set of proteins for generating high-quality affinity reagents. In this review, we focus on the use of phage librarie...

  • Article
  • Open Access
6 Citations
4,541 Views
15 Pages

High-Resolution Epitope Mapping and Affinity Binding Analysis Comparing a New Anti-Human LAG3 Rabbit Antibody Clone to the Commonly Used Mouse 17B4 Clone

  • P. Daniel Warren,
  • Mark S. Dodson,
  • Margaret H. Smith,
  • Terry H. Landowski and ,
  • John Douglas Palting and
  • Penny Towne
  • + 1 author+ 0 author

21 September 2022

Lymphocyte activation gene 3 (LAG3) is a T cell inhibitory receptor that promotes tumor cell immune escape and is a potential target for cancer diagnostic and immunotherapeutic applications. We used automated capillary electrophoresis (ACE), surface...

(This article belongs to the Special Issue Monoclonal Antibody-Directed Therapy Series II)
  • Article
  • Open Access
3 Citations
2,545 Views
19 Pages

24 December 2023

Intact Transition Epitope Mapping—One-step Non-covalent force Exploitation (ITEM-ONE) analysis reveals an assembled epitope on the surface of Pertuzumab, which is recognized by the anti-Pertuzumab affimer 00557_709097. It encompasses amino acid...

(This article belongs to the Section Biomacromolecules: Proteins, Nucleic Acids and Carbohydrates)
  • Article
  • Open Access
1 Citations
2,277 Views
16 Pages

15 November 2023

Life on the molecular scale is based on a versatile interplay of biomolecules, a feature that is relevant for the formation of macromolecular complexes. Fluorescence-based two-color coincidence detection is widely used to characterize molecular bindi...

(This article belongs to the Section Molecular Biophysics)
  • Article
  • Open Access
1 Citations
3,031 Views
11 Pages

Indium Tin Oxide-Based Voltammetric Biosensor for the Detection of Antibodies Against the SARS-CoV-2 Virus Spike Protein

  • Greta Zvirzdine,
  • Maryia Drobysh,
  • Almira Ramanaviciene,
  • Vilma Ratautaite and ,
  • Sarunas Zukauskas,
  • Migle Stanciauskaite,
  • Ieva Plikusiene and
  • Arunas Ramanavicius
  • + 3 authors+ 0 author

4 November 2025

This study aims to propose a plausible application of a novel electrochemical biosensing system for detecting antibodies against SARS-CoV-2 (anti-rS) in serum samples. The uniqueness of this study lies in the biosensor utilizing recombinant spike gly...

(This article belongs to the Special Issue Feature Papers in Biosensors Section 2025)
  • Article
  • Open Access
4 Citations
2,246 Views
17 Pages

Virtual Screening and Validation of Affinity DNA Functional Ligands for IgG Fc Segment

  • Qianyu Yang,
  • Zhiwei Liu,
  • Xinrui Xu,
  • Jiang Wang and ,
  • Bin Du,
  • Pengjie Zhang,
  • Bing Liu,
  • Xihui Mu and
  • Zhaoyang Tong
  • + 4 authors+ 0 author

The effective attachment of antibodies to the immune sensing interface is a crucial factor that determines the detection performance of immunosensors. Therefore, this study aims to investigate a novel antibody immobilization material with low molecul...

(This article belongs to the Section Molecular Biophysics)
  • Feature Paper
  • Article
  • Open Access
9 Citations
5,906 Views
15 Pages

Elucidating the Binding Mechanism of a Novel Silica-Binding Peptide

  • Rachit Bansal,
  • Zehra Elgundi,
  • Andrew Care,
  • Sophia C. Goodchild and ,
  • Megan S. Lord,
  • Alison Rodger and
  • Anwar Sunna
  • + 2 authors+ 0 author

18 December 2019

Linker-protein G (LPG) is a bifunctional fusion protein composed of a solid-binding peptide (SBP, referred as the “linker”) with high affinity to silica-based compounds and a Streptococcus protein G (PG), which binds antibodies. The bindi...

(This article belongs to the Special Issue Peptides: Molecular and Biotechnological Aspects)
  • Article
  • Open Access
3 Citations
4,240 Views
11 Pages

14 August 2019

Monoclonal antibodies with high affinity and specificity are essential for research and clinical purposes, yet remain difficult to produce. Agretope peptides that can potentiate antigen-specific antibody production have been reported recently. Here,...

(This article belongs to the Special Issue Bioactive Peptides—From Therapy to Nutrition)
  • Review
  • Open Access
32 Citations
10,467 Views
16 Pages

IgG Fc Affinity Ligands and Their Applications in Antibody-Involved Drug Delivery: A Brief Review

  • Chang Yang,
  • Bing He,
  • Hua Zhang,
  • Xueqing Wang and ,
  • Qiang Zhang and
  • Wenbing Dai
  • + 1 author+ 0 author

Antibodies are not only an important class of biotherapeutic drugs, but also are targeting moieties for achieving active targeting drug delivery. Meanwhile, the rapidly increasing application of antibodies and Fc-fusion proteins has inspired the emer...

  • Article
  • Open Access
2 Citations
9,908 Views
10 Pages

Kinetic Analyses of Data from a Human Serum Albumin Assay Using the liSPR System

  • Anja Henseleit,
  • Carolin Pohl,
  • Hans-Michael Kaltenbach,
  • Karina Hettwer and ,
  • Kirsten Simon,
  • Steffen Uhlig,
  • Natalie Haustein,
  • Thomas Bley and
  • Elke Boschke
  • + 4 authors+ 0 author

19 January 2015

We used the interaction between human serum albumin (HSA) and a high-affinity antibody to evaluate binding affinity measurements by the bench-top liSPR system (capitalis technology GmbH). HSA was immobilized directly onto a carboxylated sensor layer,...

  • Article
  • Open Access
5 Citations
3,795 Views
13 Pages

Combining Cellular Immunization and Phage Display Screening Results in Novel, FcγRI-Specific Antibodies

  • Steffen Krohn,
  • Tosca Holtrop,
  • Arianne M. Brandsma,
  • Petra Moerer and ,
  • Maaike Nederend,
  • Nikos Darzentas,
  • Monika Brüggemann,
  • Katja Klausz,
  • Jeanette H. W. Leusen and
  • Matthias Peipp
  • + 5 authors+ 0 author

12 April 2024

Antibodies that specifically bind to individual human fragment crystallizable γ receptors (FcγRs) are of interest as research tools in studying immune cell functions, as well as components in bispecific antibodies for immune cell engageme...

(This article belongs to the Special Issue Phage Display in Cancer Research)
  • Article
  • Open Access
15 Citations
4,685 Views
18 Pages

Structure Based Affinity Maturation and Characterizing of SARS-CoV Antibody CR3022 against SARS-CoV-2 by Computational and Experimental Approaches

  • Wei Yu,
  • Nan Zhong,
  • Xin Li,
  • Jiayi Ren and ,
  • Yueming Wang,
  • Chengming Li,
  • Gui Yao,
  • Rui Zhu,
  • Xiaoli Wang and
  • Xiaohui Yuan
  • + 11 authors+ 6 authors

19 January 2022

The COVID-19 epidemic is raging around the world. Neutralizing antibodies are powerful tools for the prevention and treatment of SARS-CoV-2 infection. Antibody CR3022, a SARS-CoV neutralizing antibody, was found to cross-react with SARS-CoV-2, but it...

(This article belongs to the Special Issue Antibodies and B Cell Memory in Viral Immunity)
  • Review
  • Open Access
41 Citations
11,889 Views
32 Pages

Antibodies leverage on their unique architecture to bind with an array of antigens. The strength of interaction has a direct relation to the affinity of the antibodies towards the antigen. In vivo affinity maturation is performed through multiple rou...

(This article belongs to the Special Issue Advances in Antibody Design and Antigenic Peptide Targeting)
  • Article
  • Open Access
5 Citations
3,234 Views
13 Pages

Computational and Rational Design of Single-Chain Antibody against Tick-Borne Encephalitis Virus for Modifying Its Specificity

  • Ivan K. Baykov,
  • Pavel Y. Desyukevich,
  • Ekaterina E. Mikhaylova,
  • Olga M. Kurchenko and
  • Nina V. Tikunova

29 July 2021

Tick-borne encephalitis virus (TBEV) causes 5−7 thousand cases of human meningitis and encephalitis annually. The neutralizing and protective antibody ch14D5 is a potential therapeutic agent. This antibody exhibits a high affinity for binding with th...

(This article belongs to the Section Viral Immunology, Vaccines, and Antivirals)
  • Article
  • Open Access
8 Citations
3,540 Views
14 Pages

In Silico Maturation of a Nanomolar Antibody against the Human CXCR2

  • Damiano Buratto,
  • Yue Wan,
  • Xiaojie Shi,
  • Guang Yang and
  • Francesco Zonta

13 September 2022

The steady increase in computational power in the last 50 years is opening unprecedented opportunities in biology, as computer simulations of biological systems have become more accessible and can reproduce experimental results more accurately. Here,...

(This article belongs to the Special Issue State-of-the-Art Biophysics, Biochemistry and Molecular Biology in China)
  • Article
  • Open Access
12 Citations
3,977 Views
10 Pages

13 June 2021

Glycan-targeting antibodies and pseudo-antibodies have been extensively studied for their stoichiometry, avidity, and their interactions with the rapidly modifying glycan shield of influenza A. Broadly neutralizing antiviral agents bind in the same o...

(This article belongs to the Section Organic Chemistry)
  • Article
  • Open Access
2,252 Views
21 Pages

Changes in the Interaction Properties of Antibodies with Fc Receptors upon Binding to Target Antigens

  • Artem S. Grevtsev,
  • Anton A. Kommer,
  • Irina S. Zelmanchuk,
  • Andrei S. Avdiushkin and ,
  • Elizaveta O. Ermolaeva,
  • Aleksandr A. Tiulin,
  • Darya O. Chernyshova,
  • Alexandra D. Azarian,
  • Alexandr A. Gordeev and
  • Aleksey K. Misorin
  • + 5 authors+ 0 author

14 November 2025

The interaction of therapeutic antibodies with Fc receptors is an important property that is actively modified to improve pharmacokinetic profiles and optimize antibody-dependent mechanisms of action. Various modifications of the Fc and hinge regions...

(This article belongs to the Section Biosensors and Healthcare)
  • Article
  • Open Access
6 Citations
2,333 Views
17 Pages

Ferritin Nanocages Exhibit Unique Structural Dynamics When Displaying Surface Protein

  • Monikaben Padariya,
  • Natalia Marek-Trzonkowska and
  • Umesh Kalathiya

Ferritin nanocages with spherical shells carry proteins or antigens that enable their use as highly efficient nanoreactors and nanocarriers. Mimicking the surface Spike (S) receptor-binding domain (RBD) from SARS-CoV-2, ferritin nanocages induce neut...

(This article belongs to the Special Issue 25th Anniversary of IJMS: Updates and Advances in Molecular Nanoscience)
  • Article
  • Open Access
1,674 Views
12 Pages

Background: The interaction between human immunoglobulin G (IgG)1 Fc and the Fc gamma receptor (FcγR) IIIa/CD16a elicits protective immune responses. Antibody N-glycosylation stabilizes the FcγR-binding interface and is thus essential for...

(This article belongs to the Section Antibody Discovery and Engineering)
  • Article
  • Open Access
2 Citations
6,839 Views
14 Pages

The Binding of the SARS-CoV-2 Spike Protein to Platelet Factor 4: A Proposed Mechanism for the Generation of Pathogenic Antibodies

  • Thi-Huong Nguyen,
  • Li-Yu Chen,
  • Nida Zaman Khan,
  • Annerose Lindenbauer and ,
  • Van-Chien Bui,
  • Peter F. Zipfel and
  • Doris Heinrich
  • + 2 authors+ 0 author

20 February 2024

Pathogenic platelet factor 4 (PF4) antibodies contributed to the abnormal coagulation profiles in COVID-19 and vaccinated patients. However, the mechanism of what triggers the body to produce these antibodies has not yet been clarified. Similar patte...

(This article belongs to the Special Issue Novel Insights into the Role of Autoantibodies in Diseases)
  • Article
  • Open Access
13 Citations
5,028 Views
17 Pages

Toll-like receptor (TLR) signaling plays a critical role in the induction and progression of autoimmune diseases such as rheumatoid arthritis, systemic lupus erythematous, experimental autoimmune encephalitis, type 1 diabetes mellitus and neurodegene...

(This article belongs to the Special Issue Advances in Molecular Simulation)
  • Article
  • Open Access
5 Citations
2,903 Views
13 Pages

21 November 2021

The broadly neutralizing antibody PG9 recognizes a unique glycopeptide epitope in the V1V2 domain of HIV-1 gp120 envelope glycoprotein. The present study describes the design, synthesis, and antibody-binding analysis of HIV-1 V1V2 glycopeptide-Qβ con...

(This article belongs to the Special Issue Complex Carbohydrates and Glycoconjugates: Structure, Functions and Applications 2021)
  • Article
  • Open Access
1 Citations
3,465 Views
12 Pages

Conformational Dynamics of the Receptor-Binding Domain of the SARS-CoV-2 Spike Protein

  • Aleksandra A. Mamchur,
  • Tatiana B. Stanishneva-Konovalova,
  • Yuliana A. Mokrushina,
  • Viktoria A. Abrikosova and ,
  • Yu Guo,
  • Hongkai Zhang,
  • Stanislav S. Terekhov,
  • Ivan V. Smirnov and
  • Igor A. Yaroshevich
  • + 4 authors+ 0 author

12 December 2022

Variants of SARS-CoV-2 keep emerging and causing new waves of COVID-19 around the world. Effective new approaches in drug development are based on the binding of agents, such as neutralizing monoclonal antibodies to a receptor-binding domain (RBD) of...

(This article belongs to the Special Issue Past, Present and Future of COVID-19)
  • Article
  • Open Access
5 Citations
3,975 Views
15 Pages

Discovery of Antibodies Against Endemic Coronaviruses with NGS-Based Human Fab Phage Display Platform

  • Oscar Chi-Chien Pan,
  • Sean Miller,
  • Ruchin Patel,
  • Shreya Mukhopadhyay and ,
  • Giancarlo Sarullo,
  • Gwenny Go,
  • Jennifer Galli,
  • Jamie Hessels,
  • Barbara Schlingmann-Molina and
  • Zhifeng Chen
  • + 12 authors+ 7 authors

27 March 2025

Background: There is an unmet medical need to develop a vaccine targeting endemic coronaviruses. Antigen-specific monoclonal antibodies (mAbs) are crucial for many assays to support vaccine development. Objective: In this study, we used the HuCal Fab...

  • Feature Paper
  • Review
  • Open Access
92 Citations
18,338 Views
13 Pages

16 January 2021

Tumor-targeting monoclonal antibodies (mAbs) are the most widely used and characterized immunotherapy for hematologic and solid tumors. The significance of this therapy is their direct and indirect effects on tumor cells, facilitated by the antibody&...

(This article belongs to the Special Issue Monoclonal Antibodies: Applications in Diagnosis and Immunotherapy of Cancer)
  • Article
  • Open Access
12 Citations
8,590 Views
18 Pages

Isolation and Epitope Mapping of Staphylococcal Enterotoxin B Single-Domain Antibodies

  • Kendrick B. Turner,
  • Dan Zabetakis,
  • Patricia Legler,
  • Ellen R. Goldman and
  • George P. Anderson

19 June 2014

Single-domain antibodies (sdAbs), derived from the heavy chain only antibodies found in camelids such as llamas have the potential to provide rugged detection reagents with high affinities, and the ability to refold after denaturation. We have isolat...

(This article belongs to the Special Issue Chemo- and Biosensors for Security and Defense)
  • Article
  • Open Access
3 Citations
3,839 Views
19 Pages

Re-Engineering Therapeutic Anti-Aβ Monoclonal Antibody to Target Amyloid Light Chain

  • Jingyi Bai,
  • Xi Li,
  • Jun Zhao,
  • Huifang Zong and ,
  • Yuan Yuan,
  • Lei Wang,
  • Xiaoshuai Zhang,
  • Yong Ke,
  • Lei Han and
  • Jianwei Zhu
  • + 8 authors+ 3 authors

27 January 2024

Amyloidosis involves the deposition of misfolded proteins. Even though it is caused by different pathogenic mechanisms, in aggregate, it shares similar features. Here, we tested and confirmed a hypothesis that an amyloid antibody can be engineered by...

(This article belongs to the Special Issue Drug Discovery and Application of New Technologies)
  • Article
  • Open Access
15 Citations
4,098 Views
18 Pages

Screening and Characterization of Shark-Derived VNARs against SARS-CoV-2 Spike RBD Protein

  • Yu-Lei Chen,
  • Jin-Jin Lin,
  • Huan Ma,
  • Ning Zhong and ,
  • Xin-Xin Xie,
  • Yunru Yang,
  • Peiyi Zheng,
  • Ling-Jing Zhang,
  • Tengchuan Jin and
  • Min-Jie Cao
  • + 5 authors+ 0 author

18 September 2022

The receptor-binding domain (RBD) of the SARS-CoV-2 spike protein is the major target for antibody therapeutics. Shark-derived variable domains of new antigen receptors (VNARs) are the smallest antibody fragments with flexible paratopes that can reco...

(This article belongs to the Section Molecular Immunology)

of 19